Back to top
more

CareDx (CDNA)

(Real Time Quote from BATS)

$8.24 USD

8.24
110,056

+0.20 (2.49%)

Updated Apr 23, 2024 09:44 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CDNA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for CareDx, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 235 293 348 225 38
Receivables 51 66 60 35 24
Notes Receivable 0 0 0 0 0
Inventories 19 19 17 10 6
Other Current Assets 8 9 8 4 4
Total Current Assets 314 388 433 273 72
Net Property & Equipment 35 36 22 11 4
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 86 81 87 68 69
Deposits & Other Assets 2 4 6 1 1
Total Assets 467 543 567 369 152
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 13 10 13 10 6
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 65 66 64 39 29
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 21 0
Total Current Liabilities 78 76 77 69 35
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 1 2
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 99 3 6 4 16
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 206 112 101 91 53
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 947 899 854 632 438
Retained Earnings -678 -460 -383 -353 -334
Other Equity -7 -8 -5 -2 -5
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 261 431 466 278 99
Total Liabilities & Shareholder's Equity 467 543 567 369 152
Total Common Equity 261 431 466 278 99
Shares Outstanding 54.10 53.50 52.80 49.20 42.40
Book Value Per Share 4.83 8.05 8.82 5.64 2.33

Fiscal Year End for CareDx, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 235 268 283 286
Receivables NA 51 52 52 59
Notes Receivable NA 0 0 0 0
Inventories NA 19 18 19 18
Other Current Assets NA 8 7 8 8
Total Current Assets NA 314 345 361 371
Net Property & Equipment NA 35 35 36 36
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 86 87 83 85
Deposits & Other Assets NA 2 3 3 3
Total Assets NA 467 501 515 528
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 13 9 10 13
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 65 64 65 59
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 78 73 75 72
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 5 4 4
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 206 107 110 108
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 947 937 924 912
Retained Earnings NA -678 -534 -510 -485
Other Equity NA -7 -9 -8 -7
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 261 394 405 420
Total Liabilities & Shareholder's Equity NA 467 501 515 528
Total Common Equity 0 261 394 405 420
Shares Outstanding 51.70 54.10 54.10 53.70 53.70
Book Value Per Share 0.00 4.83 7.29 7.55 7.82